PHOSPHA 250 NEUTRAL
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
64980-729 -
Package NDC
64980-729-01 -
SPL ID
f6c34864-dbd6-436e-b1e5-b1feaa61696a -
SPL set ID
9432adfc-6add-4ab4-ae93-2e2daf348be2 -
UNII
22ADO53M6F -
UNII
4J9FJ0HL51 -
UNII
593YOG76RN -
RxCUI
200251 -
RxCUI
656742
What the source publishes
- Labeler
- Rising Pharma Holdings, Inc.
- Active ingredients
- Dibasic Sodium Phosphate, Monobasic Potassium Phosphate and Monobasic Sodium Phosphate
- Form
- TABLET
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- UNAPPROVED DRUG OTHER
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
- PHOSPHA 250 NEUTRAL
- Dibasic Sodium Phosphate, Monobasic Potassium Phosphate and Monobasic Sodium Phosphate
- SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
- POTASSIUM PHOSPHATE, MONOBASIC
- SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE
Complete source data
{
"name": "PHOSPHA 250 NEUTRAL",
"splId": "f6c34864-dbd6-436e-b1e5-b1feaa61696a",
"labels": [
{
"setId": "9432adfc-6add-4ab4-ae93-2e2daf348be2",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9432adfc-6add-4ab4-ae93-2e2daf348be2",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=9432adfc-6add-4ab4-ae93-2e2daf348be2"
}
],
"routes": [
"ORAL"
],
"labeler": "Rising Pharma Holdings, Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "100 TABLET in 1 BOTTLE (64980-729-01)",
"package_ndc": "64980-729-01",
"identifierStatus": "well-formed",
"marketing_start_date": "20260328"
}
],
"productId": "64980-729_f6c34864-dbd6-436e-b1e5-b1feaa61696a",
"useDomain": "unknown",
"dosageForm": "TABLET",
"productNdc": "64980-729",
"deaSchedule": null,
"genericName": "Dibasic Sodium Phosphate, Monobasic Potassium Phosphate and Monobasic Sodium Phosphate",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "SODIUM PHOSPHATE, DIBASIC, ANHYDROUS",
"strength": "852 mg/1"
},
{
"name": "POTASSIUM PHOSPHATE, MONOBASIC",
"strength": "155 mg/1"
},
{
"name": "SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE",
"strength": "130 mg/1"
}
],
"applicationNumber": null,
"marketingCategory": "UNAPPROVED DRUG OTHER",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20260328",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"upc": [
"0364980729017"
],
"unii": [
"22ADO53M6F",
"4J9FJ0HL51",
"593YOG76RN"
],
"rxcui": [
"200251",
"656742"
],
"spl_set_id": [
"9432adfc-6add-4ab4-ae93-2e2daf348be2"
],
"manufacturer_name": [
"Rising Pharma Holdings, Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:64980-729_f6c34864-dbd6-436e-b1e5-b1feaa61696a"